TuHURA Biosciences (HURA) Cash From Financing

Annual CFF

$2.66 M
-$13.59 M-83.63%

December 1, 2023

Summary

Performance

1-Year Change

-83.63%

3-Year Change

-62.24%

5-Year Change

-62.24%

15-Year Change

-62.24%

HURA Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$16.25 M
HURA annual cash flow from financing activities is currently -83.63% below its historical high of $16.25 million

3-Year Low

$2.66 M
HURA annual cash flow from financing activities is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 1, 2023
HURA previous annual earnings announcement was published on Dec 1, 2023

Next Annual Earnings Report Date

N/A
HURA next annual earnings announcement has not yet been scheduled

OtherHURAcash flowmetrics:

Annual CFI

-$1.30 M
HURA annual cash flow from investing activities is -$1.30 million

Annual CFO

-$11.95 M
HURA annual cash flow from operations is -$11.95 million

Annual FCF

-$12.03 M
HURA annual free cash flow is -$12.03 million

Annual CAPEX

-
HURA annual capital expenditures value is unknown

Quarterly CFF

$0.00
-$12.95 M-100.00%

September 1, 2024

Summary

Performance

3-Month Change

-100%

1-Year Change

-100%

3-Year Change

0%

5-Year Change

0%

HURA Quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$12.95 M
HURA quarterly cash flow from financing activities is currently -100.00% below its historical high of $12.95 million

3-Year Low

-$150.00 K

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
HURA previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

N/A
HURA next earnings announcement has not yet been scheduled

OtherHURAcash flowmetrics:

Quarterly CFI

-
HURA quarterly cash flow from investing activities value is unknown

Quarterly CFO

-$1.89 M
HURA quarterly cash flow from operations is -$1.89 million

Quarterly FCF

-$1.89 M
HURA quarterly free cash flow is -$1.89 million

Quarterly CAPEX

-
HURA quarterly capital expenditures value is unknown

TTM CFF

$17.58 M
$0.000.00%

September 1, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

+279.7%

3-Year Change

+100%

5-Year Change

+100%

HURA TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$17.58 M
HURA TTM cash flow from financing activities is currently at an all-time high

3-Year Low

-$150.00 K

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
HURA previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

N/A
HURA next earnings announcement has not yet been scheduled

OtherHURAcash flowmetrics:

TTM CFI

-
HURA TTM cash flow from investing activities value is unknown

TTM CFO

-$10.79 M
HURA TTM cash flow from operations is -$10.79 million

TTM FCF

-$10.83 M
HURA TTM free cash flow is -$10.83 million

TTM CAPEX

-
HURA TTM capital expenditures value is unknown

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

HURA Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-83.6%-100.0%+279.7%
3 y3 years-62.2%0.0%+100.0%
5 y5 years-62.2%0.0%+100.0%

HURA Cash From Financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-83.6%at low-100.0%<-9999.0%at high-100.9%
5 y5-year-83.6%at low-100.0%<-9999.0%at high-100.9%
alltimeall time-83.6%at low-100.0%<-9999.0%at high-100.9%

TuHURA Biosciences Cash From Financing History

DateAnnualQuarterlyTTM
Sep 2024
-
$0.00(-100.0%)
$17.58 M(0.0%)
Jun 2024
-
$12.95 M(+179.7%)
$17.58 M(+279.7%)
Mar 2024
-
$4.63 M(>+9900.0%)
$4.63 M(>+9900.0%)
Dec 2023
$2.66 M
-
-
DateAnnualQuarterlyTTM
Mar 2023
-
$0.00(-100.0%)
$0.00(-100.0%)
Dec 2022
$16.25 M(+130.7%)
-
-
Mar 2022
-
-$150.00 K
-$150.00 K
Dec 2021
$7.04 M
-
-

FAQ

  • What is TuHURA Biosciences annual cash flow from financing activities?
  • What is the all time high annual CFF for TuHURA Biosciences?
  • What is TuHURA Biosciences annual CFF year-on-year change?
  • What is TuHURA Biosciences quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for TuHURA Biosciences?
  • What is TuHURA Biosciences quarterly CFF year-on-year change?
  • What is TuHURA Biosciences TTM cash flow from financing activities?
  • What is the all time high TTM CFF for TuHURA Biosciences?
  • What is TuHURA Biosciences TTM CFF year-on-year change?

What is TuHURA Biosciences annual cash flow from financing activities?

The current annual CFF of HURA is $2.66 M

What is the all time high annual CFF for TuHURA Biosciences?

TuHURA Biosciences all-time high annual cash flow from financing activities is $16.25 M

What is TuHURA Biosciences annual CFF year-on-year change?

Over the past year, HURA annual cash flow from financing activities has changed by -$13.59 M (-83.63%)

What is TuHURA Biosciences quarterly cash flow from financing activities?

The current quarterly CFF of HURA is $0.00

What is the all time high quarterly CFF for TuHURA Biosciences?

TuHURA Biosciences all-time high quarterly cash flow from financing activities is $12.95 M

What is TuHURA Biosciences quarterly CFF year-on-year change?

Over the past year, HURA quarterly cash flow from financing activities has changed by -$4.63 M (-100.00%)

What is TuHURA Biosciences TTM cash flow from financing activities?

The current TTM CFF of HURA is $17.58 M

What is the all time high TTM CFF for TuHURA Biosciences?

TuHURA Biosciences all-time high TTM cash flow from financing activities is $17.58 M

What is TuHURA Biosciences TTM CFF year-on-year change?

Over the past year, HURA TTM cash flow from financing activities has changed by +$12.95 M (+279.70%)